// App-Quantinova.ai

: AN INSPIRING RESULT OF UMBILICAL CORD BLOOD TRANSPLANTATION AFTER ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY IN CHILDREN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Fang Liu

Principal Investigators

  • Xia Chen

  • Beibei Zhao

  • Xiaojuan Chen

  • Wenyu Yang

  • Ye Guo

  • Xiaofan Zhu

Medical Centers

  • Division of Pediatrics, Department of Clinical Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Tianjin, China

  • Division of Pediatrics, Department of Clinical Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Tianjin, China

  • Division of Pediatrics, Department of Clinical Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Tianjin, China

  • Division of Pediatrics, Department of Clinical Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Tianjin, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Cyclosporine A

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved